chr6-130055238-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032438.4(L3MBTL3):c.650C>T(p.Ser217Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000632 in 1,612,882 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032438.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L3MBTL3 | NM_032438.4 | c.650C>T | p.Ser217Leu | missense_variant | 8/23 | ENST00000361794.7 | NP_115814.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L3MBTL3 | ENST00000361794.7 | c.650C>T | p.Ser217Leu | missense_variant | 8/23 | 5 | NM_032438.4 | ENSP00000354526.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 250960Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135616
GnomAD4 exome AF: 0.0000671 AC: 98AN: 1460798Hom.: 2 Cov.: 29 AF XY: 0.0000826 AC XY: 60AN XY: 726696
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2023 | The c.650C>T (p.S217L) alteration is located in exon 8 (coding exon 6) of the L3MBTL3 gene. This alteration results from a C to T substitution at nucleotide position 650, causing the serine (S) at amino acid position 217 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at